Overview
BRVE market data
Business OverviewA provider-written description of this company or fund, with its source and observation date.
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac myosin inhibitor being developed for the treatment of obstructive HCM (oHCM) and non-obstructive HCM (nHCM).
- Source
- massive
- Observed
- Cadence
- Reference data reviewed periodically
- Status
- fresh
Price HistoryDaily closing prices from recorded market data. The latest point represents the most recent completed daily period; prices can move before the next point appears.
BRVE price chart · 1M
- O
- 19.06
- H
- 19.08
- L
- 18.12
- C
- 18.76
- Vol
- 37,109.00
Daily history from Aug 6, 2026
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & PerformanceOpen, range, return and notional-volume facts calculated from daily market bars.
- Open
- $19.06
- Previous Close
- $19.54
- Day High
- $19.08
- Day Low
- $18.12
- 52 Week High
- $31.82
- 52 Week Low
- $16.89
- 7 Day Return
- -4.02%
- 30 Day Return
- -2.52%
- 90 Day Return
- -36.57%
- 1 Year Return
- —
- Daily Notional Volume
- $696K Latest daily bar volume multiplied by its closing price.
Valuation & ProfitabilityProvider-backed valuation, profitability, and range metrics for the selected company. Display-only; never feeds scores or decisions.
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.87 Diluted earnings per share over the trailing twelve months.
- Beta
- -0.04 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $16.70 – $32.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1.7B.
Company NewsRecent source-attributed headlines linked to this symbol. Repeated headlines and low-signal items are filtered. Open a headline for its source and context.
10 captured
Braveheart Bio Presents 52-Week Phase 2 Data for BHB-1893 in Obstructive Hypertrophic CardiomyopathyFiscal.ai ·
8-K filing — Braveheart Bio, Inc. (BRVE)SEC EDGAR ·
Braveheart Bio Q2 EPS $(2.51)Benzinga ·